A deep tech go to market strategy is built around selling the science before the product is finished, using joint development agreements, evaluations, and design wins instead of a finished offering, and earning credibility through third-party validation rather than promotion. The core shift from software GTM is that you manage technical risk and long qualification cycles, not market risk.
Key Takeaways
- Deep tech companies carry technical risk, not market risk, so the early "sale" is a JDA, evaluation, or design win rather than a shipped product.
- Technology readiness levels (TRLs) are a practical planning tool that tell you what marketing and sales should be doing at each stage of R&D.
- A single reference customer or design win changes everything because industrial and semiconductor buyers qualify on proof, not pitch decks.
- Non-dilutive funding, national lab partnerships, and consortia extend runway while acting as external credibility signals.
- Your highest-converting assets are peer-reviewed papers, pilots, and technical whitepapers; narrative discipline protects your reputation in a skeptical, technical market.
Most startup GTM advice assumes you have a product that is basically done and the only question is who buys it and how fast. Deep tech breaks that assumption. If you are building a new materials process, a novel sensing modality, or a compute architecture that has to clear multi-year qualification, you cannot wait until the product is finished to start selling. You have to sell the trajectory. This post is about how to build a go to market motion that survives long R&D cycles, skeptical technical buyers, and a fundraising story where the technology itself is the risk.
What Makes a Company Deep Tech?
Deep tech is usually defined by where the risk lives. A typical software startup faces market risk: will anyone pay, will the category exist, can we out-execute competitors. A deep tech company faces technical risk first. The science has to work at scale, the process has to yield, the device has to meet spec after a thousand hours of operation. The moat is not a faster feature ship or a better growth loop; it is IP, physics, or biology that is genuinely hard to replicate.
This matters for GTM because the thing you are commercializing may not exist as a shippable unit for three to five years. You are not running gtm-for-ai-startups where an application-layer product can ship in weeks and iterate on real usage. You are closer to gtm-for-hardware-startups in that there is a physical thing eventually, but the defensibility and the timeline are different: the constraint is the science, not the factory.
What Is the Core GTM Problem for Deep Tech Startups?
The core problem is that you must generate revenue, credibility, and pipeline before the product is finished. What you actually sell in the early years is rarely a product. It is one of three things. First, a joint development agreement (JDA), where a customer co-funds development in exchange for early access and preferred terms. Second, an evaluation, where a customer runs your technology in their environment against their benchmarks. Third, a design win, where your component or material is specified into a customer's product roadmap before that product ships.
None of these look like a traditional SaaS sale. There is no self-serve funnel. The sales cycle is measured in quarters and sometimes years. The buyer is often an engineer or a technical scouting team, not a line-of-business manager, and they are evaluating whether your science will still hold up when it meets their supply chain and their reliability requirements.
How Should You Use Technology Readiness Levels as a GTM Tool?
Technology readiness levels, or TRLs, give you a shared language between technical and commercial teams. They also give you a planning tool for what marketing and sales should be doing at each stage. The mistake is treating GTM as something that "starts at launch." In deep tech, commercial activity should begin at TRL 3 or 4, long before anything is shippable.
| TRL band | What the technology is doing | Right GTM motion | Success metric |
|---|---|---|---|
| TRL 3-4 | Proof of concept in lab or simulated environment | Publish, present at conferences, build scouting relationships | Qualified technical conversations started |
| TRL 6-7 | Prototype in relevant environment, pilot underway | Run paid evaluations and JDAs, target design wins | Evaluations and JDAs signed |
| TRL 8-9 | System complete and qualified, commercial deployment | Scale pipeline, expand reference accounts, shift to volume deals | Design wins converted and LOIs progressed |
The point of the table is not the labels. It is that the activity changes with the science. At TRL 3-4 your job is to be visible and credible to the right technical scouts. At TRL 6-7 your job is to convert that attention into evaluations and agreements. At TRL 8-9 your job is to turn a few hard-won reference wins into repeatable pipeline.
Why Do Design Wins and Long Qualification Cycles Matter So Much?
In semiconductors, advanced materials, and industrial systems, the buyer does not choose your product at purchase. They choose it years earlier, when they design their own product, and then they are locked in through qualification. A "design win" means your technology is specified into their bill of materials or architecture before they ever buy at volume.
These cycles are long and conservative by design. An industrial buyer qualifying a new material is betting their own product's reliability on your process. They want pilot data, they want failure-mode analysis, and they want a reference: someone like them who already shipped with you. A single reference customer changes everything, because it converts "unproven" into "proven in a comparable environment." That is why early GTM in deep tech is obsessed with landing one credible design partner rather than a hundred lukewarm leads.
How Can Non-Dilutive Funding Support Your GTM?
Non-dilutive funding is often treated as a finance topic, but it is a GTM asset. Grants, national lab partnerships, and consortia do two things at once. First, they extend runway so you can survive the long gap between TRL 4 and TRL 8 without raising on unfavorable terms. Second, they act as an external credibility signal. A national lab collaboration or a competitive grant says a technical body with no incentive to flatter you examined your science and found it credible.
For industrial and government-adjacent buyers, that signal matters as much as a customer logo. It shortens the trust step in a long qualification cycle. The discipline is to treat these programs as commercial proof points, not just money: publish the results, name the partnership where you appropriately can, and use it in the same deck where you ask for an evaluation.
Why Is Proof More Powerful Than Promotion in Deep Tech?
In a technical market, overclaiming is expensive. The people evaluating you are often more expert than your marketers, and a single unsupported claim can disqualify you. The assets that convert are proof assets: peer-reviewed publications, third-party validation, pilot data, and technical whitepapers that show the math and the failure modes honestly.
This is the inverse of consumer marketing, where a confident claim and a clean landing page can move a buyer quickly. Here, a whitepaper that admits where the technology is limited builds more trust than a glossy one that promises too much. Your highest-converting content is the document a customer's engineers forward internally to justify starting an evaluation.
How Do You Translate Physics into a Buyer Outcome Without Overclaiming?
The narrative discipline is to connect a technical property to a concrete buyer outcome, and then stop. "Our process reduces defect density by an order of magnitude, which lowers your yield loss in high-volume production" is a translation. "Our technology will transform your cost structure" is an overclaim. The first is checkable; the second is a slogan.
The reputational cost of overclaiming in deep tech is specific: the same technical community that would have been your early adopters becomes the source of your credibility problem. Buyers talk. A founder who promised a capability the lab could not yet deliver pays for it across every subsequent deal. Discipline here is not modesty; it is the cheapest insurance you have.
Should Founders Treat Talent and Investors as GTM Audiences?
Yes, and more directly than in application software. In deep tech, the scarcest resource is often senior technical talent and patient technical capital, and both are recruited through the same narrative you use with customers. A clear, honest articulation of the science and its trajectory is what convinces a principal investigator to join, or a deep-tech fund to lead your round.
This is where the link to fundraising becomes concrete. The commercial milestones you build through evaluations and design wins are also the milestones investors underwrite. If you want a clear picture of how those translate into a raise, see how-to-show-traction-to-investors. And the very first commercial relationships are the same muscle as how-to-get-your-first-customers, just with a longer horizon and a more technical buyer.
What Metrics Actually Matter for Deep Tech GTM?
Forget signup-to-paid conversion for a while. The metrics that tell you the motion is working are upstream of revenue. They are: qualified evaluations started, design wins secured, LOIs and JDAs signed, time from first contact to an evaluation, and TRL progression per quarter. These are leading indicators that the science is moving and the market is engaging at the same time.
The sequence from a first technical conversation to a design win is not random. It tends to follow a repeatable order:
- Establish credibility through publication, conference presence, or a lab partnership so a technical scout will take the meeting.
- Run a focused technical conversation that maps your capability to a specific, painful problem in their roadmap.
- Agree to an evaluation or pilot with defined benchmarks and a defined timeframe.
- Produce pilot data that survives their internal review and failure-mode analysis.
- Convert the successful evaluation into a JDA or a specified design win for their next product generation.
When you can execute that sequence reliably, you have a GTM motion, not a hope. The difference between deep tech and other startup categories is simply that the sequence is longer, the buyers are more technical, and the proof has to be real earlier. Build for that, and the long cycle becomes your moat rather than your liability.
Frequently Asked Questions
What Is the Difference Between Deep Tech and a Hardware Startup?
A hardware startup usually has a shippable product and faces market and operations risk; deep tech faces technical risk and may need years of R&D before anything is shippable. The GTM difference is that deep tech sells JDAs, evaluations, and design wins during the R&D phase, while a hardware startup can often sell a finished unit much sooner.
How Early Should Deep Tech Startups Start Commercialization?
Commercial activity should begin around TRL 3-4, well before the product is finished. At that stage the goal is credibility and scouting relationships through publication and conferences, not revenue. Starting early builds the reference and trust needed for evaluations and design wins later in the cycle.
Why Are Reference Customers So Important in Deep Tech?
Industrial and semiconductor buyers qualify on proof, not pitch decks, and a comparable customer who already shipped with you converts "unproven" into "proven in a relevant environment." A single reference customer can unlock dozens of downstream evaluations by removing the trust barrier in a long qualification cycle.
What Is the Best Way to Show Traction to Deep Tech Investors?
Show leading indicators tied to both science and market: TRL progression per quarter, qualified evaluations started, design wins, and signed JDAs or LOIs. These milestones demonstrate the technical risk is being retired on a schedule, which is what patient technical capital underwrites in a deep tech raise.